Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Low-Density Lipoprotein Test Global Market Report 2025
Request Sample Buy Now
Global Low-Density Lipoprotein Test Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Low-Density Lipoprotein Test Global Market Report 2025

By Product Type (LDL-C, LDL-P, LDL-B, Other Products ), By Component (Kits, Reagents, Devices, Other Components ), By Disease Type (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types ), By Distribution Channel (Direct Tenders, Retail), By End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Low-Density Lipoprotein Test Market Overview

• Low-Density Lipoprotein Test market size has reached to $8.52 billion in 2024

• Expected to grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%

• Growth Driver: Surge In Cardiovascular Diseases Propels Expansion Of Low-Density Lipoprotein Test Market

• Market Trend: Innovative Breakthrough Transforming The Landscape Of Low-Density Lipoprotein Test Markets

• North America was the largest region in 2024.

What Is Covered Under Low-Density Lipoprotein Test Market?

The low-density lipoprotein (LDL) test refers to a type of blood test that doctors employ to gauge a patient's bloodstream's LDL cholesterol levels. LDL testing can assess LDL levels independently or as a component of a lipid panel test. Low-density lipoprotein is an accumulation of cholesterol in the arteries that can contribute to heart attacks and strokes.

The main product types of low-density lipoprotein test are LDL-C, LDL-P, LDL-B, and other products. Low-density lipoprotein cholesterol (LDL-C) is referred to as bad cholesterol because it accumulates in the walls of your blood vessels, increasing your risk of health issues such as a heart attack or stroke. It's used to test for and measure the amount of low-density lipoprotein cholesterol (LDL-C) in the blood. The component used are kits, reagents, devices, and other components, that are used in diabetes, stroke, atherosclerosis, obesity, dyslipidemia, carotid artery disease, peripheral arterial disease, angina, and others. The distribution channel includes are direct tenders and retail, that are used by hospitals, clinics, ambulatory care, research laboratory and others.

Low-Density Lipoprotein Test Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Low-Density Lipoprotein Test Market Size 2025 And Growth Rate?

The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.52 billion in 2024 to $8.83 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to research advancements in cardiovascular medicine, increased awareness of heart health, shift in treatment paradigms, clinical guidelines and recommendations, focus on preventive healthcare.

What Is The Low-Density Lipoprotein Test Market Growth Forecast?

The low-density lipoprotein test market size is expected to see strong growth in the next few years. It will grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing healthcare expenditure, aging population demographics, rise in cardiovascular disease burden, shift towards personalized medicine, healthcare policy and guidelines. Major trends in the forecast period include rising cardiovascular disease prevalence, emphasis on preventive healthcare, personalized medicine and treatment, focus on health awareness and education, regulatory guidelines and recommendations.

The forecast of 5.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. preventive cardiology by inflating prices of direct Low-Density Lipoprotein Cholesterol(LDL-C) assays and lipoprotein electrophoresis systems developed in Sweden and Canada, resulting in delayed cardiovascular risk assessment and higher laboratory testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Low-Density Lipoprotein Test Market Segmented?

1) By Product Type: LDL-C, LDL-P, LDL-B, Other Products

2) By Component: Kits, Reagents, Devices, Other Components

3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types

4) By Distribution Channel: Direct Tenders, Retail

5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users

Subsegments:

1) By LDL-C (Low-Density Lipoprotein Cholesterol): Direct Measurement Tests, Calculated LDL-C Tests

2) By LDL-P (Low-Density Lipoprotein Particle Number): NMR (Nuclear Magnetic Resonance) Tests, Other Particle Counting Methods

3) By LDL-B (Low-Density Lipoprotein Particle Size): Gradient Gel Electrophoresis, Other Size Measurement Techniques

4) By Other Products, Lipid Panel Tests: Genetic Testing For Dyslipidemia, Point-Of-Care Testing Devices

What Is Driving The Low-Density Lipoprotein Test Market? Surge In Cardiovascular Diseases Propels Expansion Of Low-Density Lipoprotein Test Market

The rise in the prevalence of cardiovascular diseases is expected to propel the growth of the low-density lipoprotein test market going forward. Cardiovascular diseases refer to a type of condition that affects the heart or blood vessels. The LDL test is used to treat cardiovascular diseases by directly measuring low-density lipoprotein levels in the heart. For instance, in February 2024, according to the UK Parliament, a UK-based governing body, heart, and circulatory diseases account for about 25% of all deaths in England, resulting in more than 140,000 fatalities annually and approximately 480 each day, or one death every three minutes. Therefore, the rise in the prevalence of cardiovascular diseases is driving the growth of the low-density lipoprotein test industry.

What Is Driving The Low-Density Lipoprotein Test Market? Obesity Epidemic Fuels Surge In Low-Density Lipoprotein (LDI) Test Market Growth

The increasing cases of obesity are expected to boost the growth of the low-density lipoprotein test market going forward. Obesity refers to a medical condition characterized by the excessive accumulation of body fat, often resulting in an individual having a body mass index (BMI) of 30 or higher and is associated with various health risks and complications. A low-density lipoprotein (LDL) test is used in obesity to measure the level of LDL cholesterol in the blood. For instance, in March 2022, according to the World Health Organization, a Switzerland-based public health organization, over 1 billion individuals globally were affected by obesity, comprising 650 million adults, 340 million adolescents, and 39 million children, with this figure continuing to rise. Further, it is estimated that around 167 million people are expected to experience compromised health due to being overweight or obese. Therefore, the increasing cases of obesity are driving the growth of the low-density lipoprotein test industry.

Who Are The Major Players In The Global Low-Density Lipoprotein Test Market?

Major companies operating in the low-density lipoprotein test market include Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Siemens Healthineers, Laboratory Corporation of America Holdings, Merck KGaA, F Hoffmann-La Roche Ltd., Agilent Technologies Inc., BioVision Incorporated, Abcam plc, BioAssay Systems, BioChain Institute Inc., BioLegend Inc., Enzo Life Sciences Inc., GenScript Biotech Corporation

What Are The Key Trends Of The Global Low-Density Lipoprotein Test Market? Innovative Breakthrough Transforming The Landscape Of Low-Density Lipoprotein Test Markets

Product innovations are a key trend gaining popularity in the low-density lipoprotein test markets. Major companies operating in the low-density lipoprotein test market are introducing innovative products to sustain their position in the market. For instance, in July 2023, Numares Health, a Germany-based health diagnostic company launched the AXINON LDL-p Test System. It is an FDA-cleared diagnostic tool that provides a more detailed assessment of lipoproteins, offering insights into cardiac function beyond standard LDL-C measurements. Utilizing nuclear magnetic resonance (NMR) spectroscopy, the system incorporates advanced diagnostic algorithms to enhance accuracy. It helps physicians better manage patients at elevated risk for cardiovascular disease, particularly those with cardiometabolic risk factors.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Low-Density Lipoprotein Test Market? AstraZeneca Bolsters Cardiorenal Portfolio With CinCor Pharma Acquisition And Baxdrostat Integration

In February 2023, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, acquired CinCor Pharma Inc. for an undisclosed amount. With this acquisition, AstraZeneca is expected to strengthen its cardiorenal pipeline and expand it with Baxdrostat, a novel aldosterone synthase inhibitor (ASI). CinCor Pharma Inc. is a US-based clinical-last biotechnology company that develops therapies to lower LDL hypertension.

Regional Analysis For The Global Low-Density Lipoprotein Test Market

North America was the largest region in the Low-Density Lipoprotein Test market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Low-Density Lipoprotein Test Market?

The low-density lipoprotein test market includes revenues earned by entities by measuring very low-density lipoprotein (VLDL) testing and ultra low-density lipoprotein (ULDL) testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Low-Density Lipoprotein Test Industry?

The low-density lipoprotein test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the low-density lipoprotein test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Low-Density Lipoprotein Test Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.83 billion
Revenue Forecast In 2034 $10.91 billion
Growth Rate CAGR of 5.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: LDL-C, LDL-P, LDL-B, Other Products
2) By Component: Kits, Reagents, Devices, Other Components
3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types
4) By Distribution Channel: Direct Tenders, Retail
5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users Subsegments: 1) By LDL-C (Low-Density Lipoprotein Cholesterol): Direct Measurement Tests, Calculated LDL-C Tests
2) By LDL-P (Low-Density Lipoprotein Particle Number): NMR (Nuclear Magnetic Resonance) Tests, Other Particle Counting Methods
3) By LDL-B (Low-Density Lipoprotein Particle Size): Gradient Gel Electrophoresis, Other Size Measurement Techniques
4) By Other Products, Lipid Panel Tests: Genetic Testing For Dyslipidemia, Point-Of-Care Testing Devices
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Siemens Healthineers, Laboratory Corporation of America Holdings, Merck KGaA, F Hoffmann-La Roche Ltd., Agilent Technologies Inc., BioVision Incorporated, Abcam plc, BioAssay Systems, BioChain Institute Inc., BioLegend Inc., Enzo Life Sciences Inc., GenScript Biotech Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Low-Density Lipoprotein Test Market Characteristics

3. Low-Density Lipoprotein Test Market Trends And Strategies

4. Low-Density Lipoprotein Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Low-Density Lipoprotein Test Growth Analysis And Strategic Analysis Framework

5.1. Global Low-Density Lipoprotein Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Low-Density Lipoprotein Test Market Growth Rate Analysis

5.4. Global Low-Density Lipoprotein Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Low-Density Lipoprotein Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Low-Density Lipoprotein Test Total Addressable Market (TAM)

6. Low-Density Lipoprotein Test Market Segmentation

6.1. Global Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

LDL-C

LDL-P

LDL-B

Other Products

6.2. Global Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kits

Reagents

Devices

Other Components

6.3. Global Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diabetes

Stroke

Atherosclerosis

Obesity

Dyslipidaemia

Carotid Artery Disease

Peripheral Arterial Disease

Angina

Other Disease Types

6.4. Global Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Tenders

Retail

6.5. Global Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Ambulatory Care

Research Laboratory

Other End Users

6.6. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-C (Low-Density Lipoprotein Cholesterol), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Measurement Tests

Calculated LDL-C Tests

6.7. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-P (Low-Density Lipoprotein Particle Number), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

NMR (Nuclear Magnetic Resonance) Tests

Other Particle Counting Methods

6.8. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-B (Low-Density Lipoprotein Particle Size), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gradient Gel Electrophoresis

Other Size Measurement Techniques

6.9. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lipid Panel Tests

Genetic Testing For Dyslipidemia

Point-Of-Care Testing Devices

7. Low-Density Lipoprotein Test Market Regional And Country Analysis

7.1. Global Low-Density Lipoprotein Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Low-Density Lipoprotein Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Low-Density Lipoprotein Test Market

8.1. Asia-Pacific Low-Density Lipoprotein Test Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Low-Density Lipoprotein Test Market

9.1. China Low-Density Lipoprotein Test Market Overview

9.2. China Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Low-Density Lipoprotein Test Market

10.1. India Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Low-Density Lipoprotein Test Market

11.1. Japan Low-Density Lipoprotein Test Market Overview

11.2. Japan Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Low-Density Lipoprotein Test Market

12.1. Australia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Low-Density Lipoprotein Test Market

13.1. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Low-Density Lipoprotein Test Market

14.1. South Korea Low-Density Lipoprotein Test Market Overview

14.2. South Korea Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Low-Density Lipoprotein Test Market

15.1. Western Europe Low-Density Lipoprotein Test Market Overview

15.2. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Low-Density Lipoprotein Test Market

16.1. UK Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Low-Density Lipoprotein Test Market

17.1. Germany Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Low-Density Lipoprotein Test Market

18.1. France Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Low-Density Lipoprotein Test Market

19.1. Italy Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Low-Density Lipoprotein Test Market

20.1. Spain Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Low-Density Lipoprotein Test Market

21.1. Eastern Europe Low-Density Lipoprotein Test Market Overview

21.2. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Low-Density Lipoprotein Test Market

22.1. Russia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Low-Density Lipoprotein Test Market

23.1. North America Low-Density Lipoprotein Test Market Overview

23.2. North America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Low-Density Lipoprotein Test Market

24.1. USA Low-Density Lipoprotein Test Market Overview

24.2. USA Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Low-Density Lipoprotein Test Market

25.1. Canada Low-Density Lipoprotein Test Market Overview

25.2. Canada Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Low-Density Lipoprotein Test Market

26.1. South America Low-Density Lipoprotein Test Market Overview

26.2. South America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Low-Density Lipoprotein Test Market

27.1. Brazil Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Low-Density Lipoprotein Test Market

28.1. Middle East Low-Density Lipoprotein Test Market Overview

28.2. Middle East Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Low-Density Lipoprotein Test Market

29.1. Africa Low-Density Lipoprotein Test Market Overview

29.2. Africa Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Low-Density Lipoprotein Test Market Competitive Landscape And Company Profiles

30.1. Low-Density Lipoprotein Test Market Competitive Landscape

30.2. Low-Density Lipoprotein Test Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Low-Density Lipoprotein Test Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.

31.2. OPKO Health Inc.

31.3. DiaSorin S.p.A.

31.4. Boster Biological Technology Ltd.

31.5. Rockland Immunochemicals Inc.

31.6. Sekisui Diagnostics LLC

31.7. DiaSys Diagnostic Systems GmbH

31.8. Eurolyser Diagnostica GmbH

31.9. Diazyme Laboratories Inc.

31.10. Cell Biolabs Inc

31.11. Home Access Health Corporation

31.12. Thermo Fisher Scientific Inc.

31.13. Becton, Dickinson and Company

31.14. Quest Diagnostics Incorporated

31.15. SpectraCell Laboratories Inc.

32. Global Low-Density Lipoprotein Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Low-Density Lipoprotein Test Market

34. Recent Developments In The Low-Density Lipoprotein Test Market

35. Low-Density Lipoprotein Test Market High Potential Countries, Segments and Strategies

35.1 Low-Density Lipoprotein Test Market In 2029 - Countries Offering Most New Opportunities

35.2 Low-Density Lipoprotein Test Market In 2029 - Segments Offering Most New Opportunities

35.3 Low-Density Lipoprotein Test Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-C (Low-Density Lipoprotein Cholesterol), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-P (Low-Density Lipoprotein Particle Number), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-B (Low-Density Lipoprotein Particle Size), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Low-Density Lipoprotein Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Low-Density Lipoprotein Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Qiagen N.V. Financial Performance
  • Table 82: Randox Laboratories Ltd. Financial Performance
  • Table 83: Eurofins Scientific SE Financial Performance
  • Table 84: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-C (Low-Density Lipoprotein Cholesterol), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-P (Low-Density Lipoprotein Particle Number), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-B (Low-Density Lipoprotein Particle Size), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Low-Density Lipoprotein Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Low-Density Lipoprotein Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Qiagen N.V. Financial Performance
  • Figure 82: Randox Laboratories Ltd. Financial Performance
  • Figure 83: Eurofins Scientific SE Financial Performance
  • Figure 84: Danaher Corporation Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Inorganic Catalyst Global Market Report 2025 – By Type (Zeolites, Metals, Chemical Compounds, Other Types), By Process (Recycling, Regeneration, Rejuvenation), By Applications (Petroleum Refining, Chemical Synthesis, Pol...

View Report

Wire-to-Board Connector Global Market Report 2025 – By Type (Below 1.00 MM, 1.00 MM to 2.00 MM, Above 2.00 MM), By Style (Accessory, Header, Housing, Plug, Receptacle, Socket), By Application (Transportation, Consumer El...

View Report

Natural Gas Pipeline Transport Global Market Report 2025 – By Type (Gathering Pipeline, Transportation Pipeline, Distribution Pipeline), By Pipeline Component (Transmission Pipes, Compressor Stations, Metering Stations, ...

View Report

Coconut Oil Global Market Report 2025 – By Product (Virgin Coconut Oil, Coconut RBD Oil), By Price Point (Mass, Premium), By Distribution (Direct Distribution, Convenience Stores, Modern Trade Units, E-Commerce, Others D...

View Report

Bionic Contact Lenses Global Market Report 2025 – By Type (Vision Correction, Therapeutic, Augmented Reality (AR), Virtual Reality (VR)), By Application (Medical, Military, Other Applications), By Distribution Channel (H...

View Report

Hospital Daily Cash Benefit Insurance Market 2023 – By Type of Plan (Rider, Standalone Cover, Part of Health Insurance), By Benefit (Emergency Admission, Accident, Medical Treatment, Surgery), By Service Provider (Public...

View Report

Frequently Asked Questions

The low-density lipoprotein (LDL) test refers to a type of blood test that doctors employ to gauge a patient's bloodstream's LDL cholesterol levels. LDL testing can assess LDL levels independently or as a component of a lipid panel test. Low-density lipoprotein is an accumulation of cholesterol in the arteries that can contribute to heart attacks and strokes. For further insights on this market, request a sample here

The market major growth driver - Surge In Cardiovascular Diseases Propels Expansion Of Low-Density Lipoprotein Test Market. For further insights on this market, request a sample here

The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.52 billion in 2024 to $8.83 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to research advancements in cardiovascular medicine, increased awareness of heart health, shift in treatment paradigms, clinical guidelines and recommendations, focus on preventive healthcare. The low-density lipoprotein test market size is expected to see strong growth in the next few years. It will grow to " $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing healthcare expenditure, aging population demographics, rise in cardiovascular disease burden, shift towards personalized medicine, healthcare policy and guidelines. Major trends in the forecast period include rising cardiovascular disease prevalence, emphasis on preventive healthcare, personalized medicine and treatment, focus on health awareness and education, regulatory guidelines and recommendations. For further insights on this market, request a sample here

The low-density lipoprotein testmarket covered in this report is segmented –
1) By Product Type: LDL-C; LDL-P; LDL-B; Other Products
2) By Component: Kits; Reagents; Devices; Other Components
3) By Disease Type: Diabetes; Stroke; Atherosclerosis; Obesity; Dyslipidaemia; Carotid Artery Disease; Peripheral Arterial Disease; Angina; Other Disease Types
4) By Distribution Channel: Direct Tenders; Retail
5) By End User: Hospitals; Clinics; Ambulatory Care; Research Laboratory; Other End Users Subsegments:
1) By LDL-C (Low-Density Lipoprotein Cholesterol): Direct Measurement Tests; Calculated LDL-C Tests
2) By LDL-P (Low-Density Lipoprotein Particle Number): NMR (Nuclear Magnetic Resonance) Tests; Other Particle Counting Methods
3) By LDL-B (Low-Density Lipoprotein Particle Size): Gradient Gel Electrophoresis; Other Size Measurement Techniques
4) By Other Products; Lipid Panel Tests: Genetic Testing For Dyslipidemia; Point-Of-Care Testing Devices For further insights on this market, request a sample here

North America was the largest region in the Low-Density Lipoprotein Test market in 2024. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the low-density lipoprotein test market include Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Siemens Healthineers, Laboratory Corporation of America Holdings, Merck KGaA, F Hoffmann-La Roche Ltd., Agilent Technologies Inc., BioVision Incorporated, Abcam plc, BioAssay Systems, BioChain Institute Inc., BioLegend Inc., Enzo Life Sciences Inc., GenScript Biotech Corporation . For further insights on this market, request a sample here.

Major trends in this market include Innovative Breakthrough Transforming The Landscape Of Low-Density Lipoprotein Test Markets. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Low-Density Lipoprotein Test Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon